Seems like a sell on the news reaction. Based on the xconomy article OGXI won't have to raise cash for another two years. http://www.xconomy.com/seattle/2009/12/21/oncogenex-the-cinderella-story-grabs-60m-upfront-from-teva-for-rights-to-cancer-drug/?single_page=true